# Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy

> **NCT03079141** · PHASE4 · UNKNOWN · sponsor: **Leiden University Medical Center** · enrollment: 107 (estimated)

## Conditions studied

- Chronic Central Serous Chorioretinopathy

## Interventions

- **DRUG:** Eplerenone
- **OTHER:** Photodynamic therapy

## Key facts

- **NCT ID:** NCT03079141
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-20
- **Primary completion:** 2019-08-28
- **Final completion:** 2021-08
- **Target enrollment:** 107 (ESTIMATED)
- **Last updated:** 2019-10-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03079141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03079141, "Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03079141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*